Clinical updates, including trial initiations, enrollment status and data readouts and publications: Reunion, Scancell, Taran.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Alzecure, Astrazeneca, Cloudbreak, Cognition, Genentech, Ionis, Revalesio, Urogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cantargia, Bristol Meyers Squibb, Viatris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Diamedica, Galderma, Hyloris, Innovent, Novartis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Cantargia, Cognition, Cue, Okyo, Zevra.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4Teen4, Ascendis, Gilead, Hengrui, Kailera, Kairos, Sellas, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amylyx, Astrazeneca, Crinetics, Daré, Imugene, Neurocrine, Rhythm, Takeda, Verastem.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Briacell, Immix, Italfarmaco.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astellas, Mereo, Osivax, PDS, Pfizer, Tonix, Ultragenyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biovie, Daiichi Sankyo, Kazia, Leol, Rhythm.